| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/31/2013 | CN102552439B Chinese medicine for treating varicose vein of lower limb |
| 07/31/2013 | CN102552222B Magnesium sulfate wet application |
| 07/31/2013 | CN102512623B Medicine composition for treating lower limb venous thrombosis |
| 07/31/2013 | CN102512605B Traditional Chinese medicine capsule for treating piles |
| 07/31/2013 | CN102512415B Clopidogrel bisulfate medicine composition and preparation method |
| 07/31/2013 | CN102488721B Preparation method for ginkgo leaf extracts and preparation of ginkgo leaf extracts |
| 07/31/2013 | CN102370671B Active fraction in lucid ganoderma fruiting body, extracting method, application thereof and preparation |
| 07/31/2013 | CN102357208B Traditional Chinese medicine composition for treating diabetes, hyperglycemia, hypertension, and hyperlipidemia |
| 07/31/2013 | CN102210663B Diarylalkanes as potent inhibitors of binuclear enzymes |
| 07/31/2013 | CN102190661B Tricyclic benzopyran compound as anti-arrhythmic agents |
| 07/31/2013 | CN102046193B Compositions and methods for using cells to treat heart tissue |
| 07/31/2013 | CN102008374B Pearl-traditional Chinese medicine fiber cloth membrane with far infrared functions of skin care and health care and weaving method and applications thereof |
| 07/31/2013 | CN101981008B 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine II receptors |
| 07/31/2013 | CN101906455B Preparation method of egg white protein assistant antihypertensive peptides |
| 07/31/2013 | CN101756954B Schneiderian membrane medication preparation of isosorbide dinitrate and preparation method thereof |
| 07/31/2013 | CN101663293B Quinoline-carboxamide derivatives as p2y12 antagonists |
| 07/31/2013 | CN101602653B Halogenated hydroxyl aromatic methane compounds, preparation method and use thereof |
| 07/30/2013 | USRE44400 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains |
| 07/30/2013 | US8497283 Autotaxin inhibitors |
| 07/30/2013 | CA2720800C Capsule for the prevention of cardiovascular diseases |
| 07/30/2013 | CA2714700C Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/30/2013 | CA2634006C Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine |
| 07/30/2013 | CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity |
| 07/30/2013 | CA2537300C Treatment of asprin resistance with radix salviae miltiorrhizae, its extract and composition |
| 07/30/2013 | CA2479764C Hemiasterlin derivatives and uses thereof |
| 07/30/2013 | CA2462886C Flashmelt oral dosage formulation |
| 07/30/2013 | CA2451874C Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 07/30/2013 | CA2413754C Canine hepatocyte growth factor |
| 07/25/2013 | WO2013109998A1 Metalloenzyme inhibitor compounds |
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013107236A1 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 07/25/2013 | WO2013057527A3 Compounds for treatment of ischemic injury |
| 07/25/2013 | WO2013024362A3 Cardiovascular therapeutics |
| 07/25/2013 | US20130190407 Calcium receptor-active molecules |
| 07/25/2013 | US20130190400 Method for producing gamma-aminobutyric acid and food produced thereby |
| 07/25/2013 | US20130189338 Bone fibers having extended length |
| 07/25/2013 | US20130189297 Dietary Supplement For Vascular Health |
| 07/25/2013 | US20130189296 COMPOSITION FOR USE IN INHIBITING OR KILLING Phrphyromonas gingivalis AND USE IN APPLICATIONS FOR ALLEVIATING OR TREATING PERIDONTAL DISEASE AND RELATED DISEASES |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | CA2861339A1 Metalloenzyme inhibitor compounds |
| 07/24/2013 | EP2617811A1 Method for manufacturing multilayered cell sheet, multilayered cell sheet having vascular network obtained thereby, method of use thereof |
| 07/24/2013 | EP2617737A1 High purity heparin and production method therefor |
| 07/24/2013 | EP2617722A1 Hetero ring-fused imidazole derivative having ampk activating effect |
| 07/24/2013 | EP2616449A1 Anthraquinone compounds and their uses |
| 07/24/2013 | EP2616448A1 Substituted phenylacetate and phenylpropane amides and use thereof |
| 07/24/2013 | CN1863800B Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/24/2013 | CN1822845B Means for preventing and treating cellular death and their biological applications |
| 07/24/2013 | CN1462191B Treatment of ocute coronary syndrome with GLP-1 |
| 07/24/2013 | CN103221405A Substituted pyridine compound |
| 07/24/2013 | CN103221401A Process for preparing benzofuran derivatives substituted at position 5 |
| 07/24/2013 | CN103221066A Sustained-release pharmaceutical composition |
| 07/24/2013 | CN103214591A 2,5-anhydrated talose or derivatives thereof terminal low-molecular-weight glycosaminoglycan derivative |
| 07/24/2013 | CN103214576A IL-17 receptor A antigen binding proteins |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214479A Pyrazole naphthylurea tyrosine kinase inhibitor and its application |
| 07/24/2013 | CN103214471A Novel compound |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103214370A 1, 6-O-dicaffeoyl sorbitol ester as well as derivative thereof and application |
| 07/24/2013 | CN103212085A Molecules for targeting compounds to various selected organs or tissues |
| 07/24/2013 | CN103212063A Treating dyspnea associated with acute heart failure by relaxin |
| 07/24/2013 | CN103212049A Medicament for treating Raynaud syndrome |
| 07/24/2013 | CN103212046A Traditional Chinese medicine preparation for treating coronary heart diseases |
| 07/24/2013 | CN103212044A Traditional Chinese medicine composition for treating cardiovascular diseases |
| 07/24/2013 | CN103212041A Chinese medicinal composition treating coronary heart disease |
| 07/24/2013 | CN103212029A Medicine for treating coronary heart diseases |
| 07/24/2013 | CN103212009A Medicine for treating cardiovascular and cerebtovascular diseases |
| 07/24/2013 | CN103211981A Traditional Chinese medicine for treating heart disease |
| 07/24/2013 | CN103211979A New use of dendrobium officinale kimura et migo in diabetic complication prevention and treatment |
| 07/24/2013 | CN103211936A Chinese and western medicine composite preparation |
| 07/24/2013 | CN103211930A Traditional Chinese preparation for reducing blood fat and blood pressure |
| 07/24/2013 | CN103211929A Traditional Chinese medicine for treating cerebral thrombosis |
| 07/24/2013 | CN103211911A Medicine for treating thromboangiitis obliterans |
| 07/24/2013 | CN103211910A Detoxifying and lipid reducing capsules and preparation method thereof |
| 07/24/2013 | CN103211904A Medicament for treating hypotension |
| 07/24/2013 | CN103211876A Traditional Chinese medicine compound Shenfu drop pill, and preparation raw materials, preparation method and application thereof |
| 07/24/2013 | CN103211866A Soft capsule used for improving body immunity and heart and cerebral vessel function |
| 07/24/2013 | CN103211865A Compound medicine for treating coronary heart disease and preparation method thereof |
| 07/24/2013 | CN103211863A Drug for treatment of lower limb varicosity |
| 07/24/2013 | CN103211855A Application of Eucommia ulmoides xylem in preparation of health-care product |
| 07/24/2013 | CN103211830A Traditional Chinese medicine composition for treating hypertension |
| 07/24/2013 | CN103211824A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 07/24/2013 | CN103211822A Use of sterol derivatives in inhibition of lipase |
| 07/24/2013 | CN103211816A Compound double-layer tablet containing atenolol and amlodipine |
| 07/24/2013 | CN103211815A Valsartan amlodipine tablet composition and preparation method |
| 07/24/2013 | CN103211812A Application of SKF96365 in treatment of cerebral angiospasm after subarachnoid hemorrhage |
| 07/24/2013 | CN103211798A Losartan potassium membrane controlled-release pellet capsule |
| 07/24/2013 | CN103211797A Verapamil hydrochloride film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211793A Felodipine film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211792A Metoprolol fumarate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211788A Nifedipine film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211769A Method of preparing a controlled release particle of soy isoflavone with biodegradable polymer using a supercritical fluid extraction of emulsion (SFEE) process |
| 07/24/2013 | CN103211768A Isosorbide mononitrate sustained-release pellet, and isosorbide mononitrate quick-release and sustained-release pellet capsule adopting it |
| 07/24/2013 | CN103211766A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/24/2013 | CN103211760A Clevidipine butyrate intralipid and preparation method thereof |
| 07/24/2013 | CN103211759A Puerarin nanocrystalline medical composition and preparation method thereof |
| 07/24/2013 | CN103211750A Method of preparing soy isoflavone nanoparticles by precipitation with compressed antisolvent (PCA) using a supercritical fluid |
| 07/24/2013 | CN102764304B Method for improving non-oxidation rate of flavonoids in lotus leaves |
| 07/24/2013 | CN102671147B Chinese medicine formula for curing cerebral thrombosis |